Share Price and Basic Stock Data
Last Updated: January 2, 2026, 8:19 pm
| PEG Ratio | 0.65 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Religare Enterprises Ltd operates within the finance and investments sector, reporting a recent price of ₹248 and a market capitalization of ₹8,227 Cr. The company has shown a consistent upward trajectory in its revenue, with sales standing at ₹4,679 Cr for the fiscal year ending March 2023, and projected to reach ₹7,385 Cr by March 2025. Notably, quarterly sales increased from ₹1,164 Cr in September 2022 to ₹1,584 Cr in September 2023, evidencing a strong growth trend. The trailing twelve months (TTM) revenue reached ₹7,618 Cr, indicating that the company is effectively capitalizing on market opportunities. The operating profit margin (OPM) has fluctuated, standing at 10% in March 2023, but is expected to decline to 5% by March 2025. This volatility highlights the need for careful cost management amidst revenue growth. The robust sales figures and the strong market presence underscore Religare’s potential in the finance sector, although the declining profit margins signal challenges in maintaining profitability amidst rising expenses.
Profitability and Efficiency Metrics
Religare Enterprises Ltd reported a net profit of ₹3,169 Cr for the fiscal year ending March 2023, a significant recovery from prior losses, but anticipated to drop to ₹183 Cr by March 2025. The company’s return on equity (ROE) stood at 5.15%, while the return on capital employed (ROCE) was recorded at 8.39%, indicating moderate efficiency in generating returns for shareholders. Despite these figures, the interest coverage ratio (ICR) is robust at 9.22x, suggesting that the company can comfortably meet its interest obligations. However, the operating profit margin has been inconsistent, declining from 10% in March 2023 to an expected 5% in March 2025. Additionally, the cash conversion cycle (CCC) has improved to just 4 days, reflecting enhanced operational efficiency. Conversely, significant fluctuations in net profit and margins pose risks to sustained profitability, requiring a strategic focus on cost control and revenue enhancement to maintain competitive positioning in the market.
Balance Sheet Strength and Financial Ratios
The balance sheet of Religare Enterprises Ltd appears stable, with total liabilities amounting to ₹11,229 Cr against total assets of ₹12,505 Cr as of March 2025. The company has maintained a low level of borrowings, which stood at ₹319 Cr, highlighting prudent financial management. Reserves have increased to ₹2,575 Cr, indicating a solid capital base. The price-to-book value ratio is reported at 3.09x, which is relatively high, suggesting the stock may be overvalued compared to its book value. The current and quick ratios are healthy at 3.68x, reflecting strong liquidity and the ability to cover short-term liabilities. Additionally, the total debt-to-equity ratio is a low 0.08x, indicating minimal reliance on debt for financing. However, the declining operating and net profit margins raise concerns regarding profitability sustainability. The financial ratios suggest a cautious approach is warranted, as the company navigates through fluctuating revenues and changing market conditions.
Shareholding Pattern and Investor Confidence
Religare’s shareholding pattern reveals a diverse ownership structure with promoters holding 25.83% of shares as of September 2025, a significant increase from 0% earlier in the reporting period. Foreign Institutional Investors (FIIs) now hold 7.81%, while Domestic Institutional Investors (DIIs) possess 10.27%, indicating a growing confidence in the company among institutional investors. The public holds the majority at 56.11%, reflecting broad retail participation. The number of shareholders has risen to 85,873, highlighting increasing investor interest. However, the decline in FIIs from 18.79% in December 2022 to the current 7.81% raises questions about foreign investor sentiment. The fluctuating shareholding dynamics could influence stock performance, particularly if institutional confidence wanes. Overall, while the promoter stake increase signals commitment, the decline in FII holdings could point to potential concerns regarding the company’s future growth trajectory.
Outlook, Risks, and Final Insight
Looking ahead, Religare Enterprises Ltd faces both opportunities and challenges. The company’s strong revenue growth trajectory and improved operational efficiency position it well within the finance sector. However, risks include declining profit margins and fluctuating investor confidence, particularly among FIIs. If the company can effectively manage costs and enhance profitability, it may sustain its growth momentum. Conversely, failure to address margin pressures and maintain investor confidence could hinder its performance. The outlook is contingent on strategic initiatives aimed at stabilizing profit margins while leveraging revenue growth. Overall, Religare’s potential remains promising, but navigating the outlined risks will be crucial for achieving long-term success and shareholder value enhancement.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.8 Cr. | 40.3 | 65.6/36.4 | 47.2 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,484 Cr. | 313 | 484/280 | 16.0 | 111 | 0.32 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 30.2 Cr. | 0.43 | 1.74/0.38 | 4.19 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 5.04 Cr. | 10.2 | 11.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 21.8 Cr. | 42.4 | 69.9/38.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,294.71 Cr | 1,366.77 | 77.89 | 3,844.57 | 0.35% | 21.71% | 14.20% | 7.28 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,164 | 1,165 | 1,396 | 1,285 | 1,584 | 1,511 | 1,856 | 1,710 | 1,952 | 1,664 | 2,028 | 1,861 | 2,064 |
| Expenses | 1,117 | 1,020 | 1,149 | 1,147 | 1,483 | 1,455 | 1,833 | 1,653 | 1,876 | 1,730 | 1,796 | 1,846 | 2,003 |
| Operating Profit | 47 | 145 | 247 | 138 | 101 | 56 | 23 | 57 | 76 | -66 | 232 | 15 | 61 |
| OPM % | 4% | 12% | 18% | 11% | 6% | 4% | 1% | 3% | 4% | -4% | 11% | 1% | 3% |
| Other Income | 19 | 3 | 3,354 | 18 | 1 | 27 | 249 | 5 | 19 | 6 | 13 | 10 | 18 |
| Interest | 197 | 213 | 29 | 26 | 25 | 24 | 18 | 13 | 13 | 5 | 6 | 7 | 10 |
| Depreciation | 13 | 14 | 14 | 19 | 18 | 18 | 17 | 16 | 15 | 14 | 17 | 13 | 12 |
| Profit before tax | -144 | -79 | 3,557 | 112 | 59 | 41 | 236 | 33 | 67 | -79 | 222 | 6 | 57 |
| Tax % | 22% | 22% | 1% | 17% | 32% | 18% | 23% | 18% | -2% | -20% | 32% | -42% | 20% |
| Net Profit | -177 | -96 | 3,517 | 93 | 40 | 34 | 181 | 27 | 69 | -63 | 151 | 8 | 46 |
| EPS in Rs | -6.49 | -3.62 | 107.61 | 1.94 | 0.78 | 0.59 | 3.80 | 0.55 | 1.55 | -1.30 | 3.00 | 0.31 | 1.17 |
Last Updated: December 29, 2025, 9:16 am
Below is a detailed analysis of the quarterly data for Religare Enterprises Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 2,064.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,861.00 Cr. (Jun 2025) to 2,064.00 Cr., marking an increase of 203.00 Cr..
- For Expenses, as of Sep 2025, the value is 2,003.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,846.00 Cr. (Jun 2025) to 2,003.00 Cr., marking an increase of 157.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Jun 2025) to 61.00 Cr., marking an increase of 46.00 Cr..
- For OPM %, as of Sep 2025, the value is 3.00%. The value appears strong and on an upward trend. It has increased from 1.00% (Jun 2025) to 3.00%, marking an increase of 2.00%.
- For Other Income, as of Sep 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Jun 2025) to 18.00 Cr., marking an increase of 8.00 Cr..
- For Interest, as of Sep 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Jun 2025) to 10.00 Cr., marking an increase of 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 13.00 Cr. (Jun 2025) to 12.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 57.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Jun 2025) to 57.00 Cr., marking an increase of 51.00 Cr..
- For Tax %, as of Sep 2025, the value is 20.00%. The value appears to be increasing, which may not be favorable. It has increased from -42.00% (Jun 2025) to 20.00%, marking an increase of 62.00%.
- For Net Profit, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Jun 2025) to 46.00 Cr., marking an increase of 38.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.17. The value appears strong and on an upward trend. It has increased from 0.31 (Jun 2025) to 1.17, marking an increase of 0.86.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:44 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,361 | 4,128 | 4,895 | 3,709 | 2,675 | 2,371 | 2,384 | 2,513 | 3,227 | 4,679 | 6,266 | 7,385 | 7,618 |
| Expenses | 1,585 | 2,006 | 3,710 | 1,659 | 2,841 | 3,005 | 2,341 | 2,235 | 3,592 | 4,196 | 5,898 | 7,029 | 7,375 |
| Operating Profit | 1,775 | 2,122 | 1,184 | 2,050 | -167 | -634 | 43 | 278 | -364 | 483 | 368 | 356 | 243 |
| OPM % | 53% | 51% | 24% | 55% | -6% | -27% | 2% | 11% | -11% | 10% | 6% | 5% | 3% |
| Other Income | 25 | 58 | 1,012 | -316 | 60 | 10 | -157 | 17 | 137 | 3,473 | 263 | 12 | 47 |
| Interest | 1,584 | 1,658 | 1,879 | 1,840 | 1,271 | 854 | 855 | 733 | 750 | 641 | 112 | 63 | 28 |
| Depreciation | 34 | 37 | 36 | 31 | 30 | 26 | 61 | 59 | 53 | 56 | 72 | 62 | 56 |
| Profit before tax | 182 | 485 | 282 | -136 | -1,407 | -1,504 | -1,030 | -497 | -1,031 | 3,259 | 448 | 243 | 206 |
| Tax % | 85% | 34% | 79% | -10% | -16% | -0% | 1% | -4% | 49% | 3% | 22% | 25% | |
| Net Profit | 27 | 321 | 61 | -124 | -1,181 | -1,501 | -1,038 | -478 | -1,539 | 3,169 | 347 | 183 | 142 |
| EPS in Rs | -4.63 | 8.62 | -2.67 | -9.77 | -58.56 | -59.33 | -36.12 | -19.60 | -48.43 | 95.24 | 7.06 | 3.79 | 3.18 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 1088.89% | -81.00% | -303.28% | -852.42% | -27.10% | 30.85% | 53.95% | -221.97% | 305.91% | -89.05% | -47.26% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1169.89% | -222.28% | -549.14% | 825.32% | 57.94% | 23.10% | -275.92% | 527.88% | -394.96% | 41.79% |
Religare Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 25% |
| 3 Years: | 32% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 17% |
| 3 Years: | 28% |
| TTM: | 78% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 46% |
| 3 Years: | 21% |
| 1 Year: | -6% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 4% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 1:05 pm
Balance Sheet
Last Updated: December 4, 2025, 1:53 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 150 | 178 | 178 | 178 | 178 | 217 | 258 | 259 | 319 | 324 | 330 | 331 | 331 |
| Reserves | 2,982 | 3,705 | 3,660 | 2,549 | 1,658 | 616 | -157 | -306 | -1,301 | 1,734 | 2,013 | 2,185 | 2,575 |
| Borrowings | 14,073 | 16,491 | 20,247 | 14,956 | 9,945 | 6,717 | 5,356 | 4,940 | 4,878 | 841 | 443 | 233 | 319 |
| Other Liabilities | 3,920 | 5,064 | 3,344 | 3,355 | 2,081 | 2,023 | 2,673 | 3,832 | 5,467 | 5,193 | 6,686 | 8,480 | 9,280 |
| Total Liabilities | 21,125 | 25,439 | 27,429 | 21,038 | 13,862 | 9,573 | 8,130 | 8,725 | 9,362 | 8,092 | 9,472 | 11,229 | 12,505 |
| Fixed Assets | 1,981 | 2,128 | 1,785 | 103 | 80 | 83 | 175 | 117 | 127 | 196 | 161 | 145 | 137 |
| CWIP | 12 | 4 | 4 | 12 | 11 | 14 | 13 | 12 | 2 | 5 | 6 | 8 | 0 |
| Investments | 3,344 | 4,363 | 2,700 | 1,983 | 1,197 | 1,438 | 2,023 | 3,190 | 3,836 | 5,094 | 6,718 | 8,700 | 9,924 |
| Other Assets | 15,788 | 18,944 | 22,941 | 18,940 | 12,574 | 8,038 | 5,919 | 5,406 | 5,397 | 2,797 | 2,587 | 2,376 | 2,444 |
| Total Assets | 21,125 | 25,439 | 27,429 | 21,038 | 13,862 | 9,573 | 8,130 | 8,725 | 9,362 | 8,092 | 9,472 | 11,229 | 12,505 |
Below is a detailed analysis of the balance sheet data for Religare Enterprises Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 331.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 331.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,575.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,185.00 Cr. (Mar 2025) to 2,575.00 Cr., marking an increase of 390.00 Cr..
- For Borrowings, as of Sep 2025, the value is 319.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 233.00 Cr. (Mar 2025) to 319.00 Cr., marking an increase of 86.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 9,280.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,480.00 Cr. (Mar 2025) to 9,280.00 Cr., marking an increase of 800.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 12,505.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,229.00 Cr. (Mar 2025) to 12,505.00 Cr., marking an increase of 1,276.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 137.00 Cr.. The value appears to be declining and may need further review. It has decreased from 145.00 Cr. (Mar 2025) to 137.00 Cr., marking a decrease of 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 8.00 Cr..
- For Investments, as of Sep 2025, the value is 9,924.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,700.00 Cr. (Mar 2025) to 9,924.00 Cr., marking an increase of 1,224.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,444.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,376.00 Cr. (Mar 2025) to 2,444.00 Cr., marking an increase of 68.00 Cr..
- For Total Assets, as of Sep 2025, the value is 12,505.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,229.00 Cr. (Mar 2025) to 12,505.00 Cr., marking an increase of 1,276.00 Cr..
Notably, the Reserves (2,575.00 Cr.) exceed the Borrowings (319.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -13.00 | -14.00 | -19.00 | -12.00 | -176.00 | -640.00 | 38.00 | 274.00 | -368.00 | -358.00 | -75.00 | 123.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 52 | 52 | 35 | 60 | 42 | 53 | 14 | 28 | 21 | 14 | 8 | 4 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 52 | 52 | 35 | 60 | 42 | 53 | 14 | 28 | 21 | 14 | 8 | 4 |
| Working Capital Days | -303 | -326 | -257 | -187 | -250 | -224 | -352 | -264 | -387 | -275 | -291 | -334 |
| ROCE % | 11% | 11% | 9% | 10% | -1% | -7% | -0% | 4% | -6% | 16% | 9% | 8% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Large and Midcap Fund | 9,900,000 | 1.62 | 245.32 | 11,434,626 | 2025-12-15 07:59:16 | -13.42% |
| Motilal Oswal ELSS Tax Saver Fund | 4,488,708 | 2.5 | 111.23 | 4,488,808 | 2025-12-15 04:04:44 | -0% |
| Motilal Oswal Focused Fund | 3,125,339 | 5.09 | 77.45 | 2,022,299 | 2025-12-08 05:05:53 | 54.54% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.79 | 7.13 | 96.06 | -51.33 | -19.65 |
| Diluted EPS (Rs.) | 3.78 | 7.07 | 94.67 | -51.33 | -19.65 |
| Cash EPS (Rs.) | 7.42 | 12.71 | 99.67 | -46.58 | -16.15 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 76.09 | 70.96 | 63.59 | -16.69 | 11.48 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 76.09 | 70.96 | 63.59 | -16.69 | 11.48 |
| Revenue From Operations / Share (Rs.) | 222.41 | 189.09 | 144.53 | 101.11 | 95.86 |
| PBDIT / Share (Rs.) | 10.36 | 11.60 | 20.20 | -7.46 | 11.04 |
| PBIT / Share (Rs.) | 8.48 | 9.43 | 18.46 | -9.14 | 8.77 |
| PBT / Share (Rs.) | 7.36 | 13.58 | 100.71 | -32.34 | -19.17 |
| Net Profit / Share (Rs.) | 5.54 | 10.54 | 97.93 | -48.26 | -18.41 |
| NP After MI And SOA / Share (Rs.) | 3.79 | 7.06 | 95.24 | -48.43 | -19.60 |
| PBDIT Margin (%) | 4.65 | 6.13 | 13.97 | -7.38 | 11.51 |
| PBIT Margin (%) | 3.81 | 4.98 | 12.77 | -9.03 | 9.15 |
| PBT Margin (%) | 3.30 | 7.18 | 69.68 | -31.98 | -20.00 |
| Net Profit Margin (%) | 2.49 | 5.57 | 67.75 | -47.72 | -19.21 |
| NP After MI And SOA Margin (%) | 1.70 | 3.73 | 65.89 | -47.89 | -20.44 |
| Return on Networth / Equity (%) | 4.97 | 9.95 | 149.76 | 0.00 | 0.00 |
| Return on Capital Employeed (%) | 3.36 | 4.56 | 10.92 | -19.54 | 10.06 |
| Return On Assets (%) | 1.11 | 2.43 | 38.07 | -16.50 | -5.82 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | -11.92 |
| Total Debt / Equity (X) | 0.08 | 0.18 | 0.35 | -4.92 | -103.85 |
| Asset Turnover Ratio (%) | 0.70 | 0.70 | 0.53 | 0.00 | 0.00 |
| Current Ratio (X) | 3.68 | 3.25 | 2.81 | 1.11 | 1.16 |
| Quick Ratio (X) | 3.68 | 3.25 | 2.81 | 1.11 | 1.16 |
| Inventory Turnover Ratio (X) | 2704.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 9.22 | 4.09 | 1.04 | -0.32 | 0.39 |
| Interest Coverage Ratio (Post Tax) (X) | 5.94 | 2.25 | 0.80 | -1.08 | 0.34 |
| Enterprise Value (Cr.) | 7823.51 | 7089.94 | 5230.88 | 7032.76 | 5988.22 |
| EV / Net Operating Revenue (X) | 1.06 | 1.14 | 1.12 | 2.18 | 2.41 |
| EV / EBITDA (X) | 22.85 | 18.53 | 8.01 | -29.55 | 20.91 |
| MarketCap / Net Operating Revenue (X) | 1.06 | 1.11 | 1.00 | 1.29 | 0.91 |
| Price / BV (X) | 3.09 | 2.95 | 2.28 | -4.22 | -48.26 |
| Price / Net Operating Revenue (X) | 1.06 | 1.11 | 1.00 | 1.29 | 0.91 |
| EarningsYield | 0.01 | 0.03 | 0.65 | -0.37 | -0.22 |
After reviewing the key financial ratios for Religare Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.79. This value is below the healthy minimum of 5. It has decreased from 7.13 (Mar 24) to 3.79, marking a decrease of 3.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.78. This value is below the healthy minimum of 5. It has decreased from 7.07 (Mar 24) to 3.78, marking a decrease of 3.29.
- For Cash EPS (Rs.), as of Mar 25, the value is 7.42. This value is within the healthy range. It has decreased from 12.71 (Mar 24) to 7.42, marking a decrease of 5.29.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 76.09. It has increased from 70.96 (Mar 24) to 76.09, marking an increase of 5.13.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 76.09. It has increased from 70.96 (Mar 24) to 76.09, marking an increase of 5.13.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 222.41. It has increased from 189.09 (Mar 24) to 222.41, marking an increase of 33.32.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 10.36. This value is within the healthy range. It has decreased from 11.60 (Mar 24) to 10.36, marking a decrease of 1.24.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.48. This value is within the healthy range. It has decreased from 9.43 (Mar 24) to 8.48, marking a decrease of 0.95.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.36. This value is within the healthy range. It has decreased from 13.58 (Mar 24) to 7.36, marking a decrease of 6.22.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.54. This value is within the healthy range. It has decreased from 10.54 (Mar 24) to 5.54, marking a decrease of 5.00.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.79. This value is within the healthy range. It has decreased from 7.06 (Mar 24) to 3.79, marking a decrease of 3.27.
- For PBDIT Margin (%), as of Mar 25, the value is 4.65. This value is below the healthy minimum of 10. It has decreased from 6.13 (Mar 24) to 4.65, marking a decrease of 1.48.
- For PBIT Margin (%), as of Mar 25, the value is 3.81. This value is below the healthy minimum of 10. It has decreased from 4.98 (Mar 24) to 3.81, marking a decrease of 1.17.
- For PBT Margin (%), as of Mar 25, the value is 3.30. This value is below the healthy minimum of 10. It has decreased from 7.18 (Mar 24) to 3.30, marking a decrease of 3.88.
- For Net Profit Margin (%), as of Mar 25, the value is 2.49. This value is below the healthy minimum of 5. It has decreased from 5.57 (Mar 24) to 2.49, marking a decrease of 3.08.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.70. This value is below the healthy minimum of 8. It has decreased from 3.73 (Mar 24) to 1.70, marking a decrease of 2.03.
- For Return on Networth / Equity (%), as of Mar 25, the value is 4.97. This value is below the healthy minimum of 15. It has decreased from 9.95 (Mar 24) to 4.97, marking a decrease of 4.98.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 10. It has decreased from 4.56 (Mar 24) to 3.36, marking a decrease of 1.20.
- For Return On Assets (%), as of Mar 25, the value is 1.11. This value is below the healthy minimum of 5. It has decreased from 2.43 (Mar 24) to 1.11, marking a decrease of 1.32.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. It has decreased from 0.18 (Mar 24) to 0.08, marking a decrease of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.70. There is no change compared to the previous period (Mar 24) which recorded 0.70.
- For Current Ratio (X), as of Mar 25, the value is 3.68. This value exceeds the healthy maximum of 3. It has increased from 3.25 (Mar 24) to 3.68, marking an increase of 0.43.
- For Quick Ratio (X), as of Mar 25, the value is 3.68. This value exceeds the healthy maximum of 2. It has increased from 3.25 (Mar 24) to 3.68, marking an increase of 0.43.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2,704.86. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 2,704.86, marking an increase of 2,704.86.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.22. This value is within the healthy range. It has increased from 4.09 (Mar 24) to 9.22, marking an increase of 5.13.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.94. This value is within the healthy range. It has increased from 2.25 (Mar 24) to 5.94, marking an increase of 3.69.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,823.51. It has increased from 7,089.94 (Mar 24) to 7,823.51, marking an increase of 733.57.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.14 (Mar 24) to 1.06, marking a decrease of 0.08.
- For EV / EBITDA (X), as of Mar 25, the value is 22.85. This value exceeds the healthy maximum of 15. It has increased from 18.53 (Mar 24) to 22.85, marking an increase of 4.32.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.11 (Mar 24) to 1.06, marking a decrease of 0.05.
- For Price / BV (X), as of Mar 25, the value is 3.09. This value exceeds the healthy maximum of 3. It has increased from 2.95 (Mar 24) to 3.09, marking an increase of 0.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.11 (Mar 24) to 1.06, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Religare Enterprises Ltd:
- Net Profit Margin: 2.49%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.36% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.97% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.94
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.68
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 78.8 (Industry average Stock P/E: 77.89)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.49%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 1407, 14th Floor, Chiranjiv Tower, New Delhi Delhi 110019 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Malay Kumar Sinha | Chairperson (NonExe.&Ind.Director) |
| Mr. Ranjan Dwivedi | Ind. Non-Executive Director |
| Mr. Praveen Kumar Tripathi | Ind. Non-Executive Director |
| Ms. Preeti Madan | Ind. Non-Executive Director |
| Mr. Rajender Mohan Malla | Ind. Non-Executive Director |
| Mr. Gurumurthy Ramanathan | Ind. Non-Executive Director |
| Mr. Shrikant Shreeniwas Somani | Ind. Non-Executive Director |
| Mr. Suresh Mahalingam | Non Exe.Non Ind.Director |
| Mr. Arjun Lamba | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Religare Enterprises Ltd?
Religare Enterprises Ltd's intrinsic value (as of 02 January 2026) is ₹290.75 which is 16.77% higher the current market price of ₹249.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹8,280 Cr. market cap, FY2025-2026 high/low of ₹314/202, reserves of ₹2,575 Cr, and liabilities of ₹12,505 Cr.
What is the Market Cap of Religare Enterprises Ltd?
The Market Cap of Religare Enterprises Ltd is 8,280 Cr..
What is the current Stock Price of Religare Enterprises Ltd as on 02 January 2026?
The current stock price of Religare Enterprises Ltd as on 02 January 2026 is ₹249.
What is the High / Low of Religare Enterprises Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Religare Enterprises Ltd stocks is ₹314/202.
What is the Stock P/E of Religare Enterprises Ltd?
The Stock P/E of Religare Enterprises Ltd is 78.8.
What is the Book Value of Religare Enterprises Ltd?
The Book Value of Religare Enterprises Ltd is 87.8.
What is the Dividend Yield of Religare Enterprises Ltd?
The Dividend Yield of Religare Enterprises Ltd is 0.00 %.
What is the ROCE of Religare Enterprises Ltd?
The ROCE of Religare Enterprises Ltd is 8.39 %.
What is the ROE of Religare Enterprises Ltd?
The ROE of Religare Enterprises Ltd is 5.15 %.
What is the Face Value of Religare Enterprises Ltd?
The Face Value of Religare Enterprises Ltd is 10.0.